Le Lézard
Classified in: Health, Science and technology
Subjects: SVY, MIN

LEGACY RANKS BEST AND WORST US STATES FOR SPERM HEALTH, LEVERAGING PROPRIETARY DATABASE


NEW YORK, April 29, 2024 /PRNewswire/ -- Legacy, the nation's largest sperm testing and freezing company, analyzed more than 20,000 client sperm samples to compile a list of the best and worst states for sperm health.

For this ranking, the company looked at sperm concentration, the number of sperm per milliliter of semen. The team ranked the 48 contiguous states served by Legacy, plus Washington, DC.

Highest average sperm concentration

  1. Wyoming (56.8 million/mL)
  2. Idaho (55.6)
  3. Montana (54.4)
  4. Iowa (51.3)
  5. Washington, D.C. (49.1)
  6. Minnesota (45.4)
  7. Vermont (45.2)
  8. Maryland (41.0)
  9. Illinois (41.0)
  10. Pennsylvania (40.2)

Lowest average sperm concentration

  1. Mississippi (25.7 million/mL)
  2. South Carolina (28.9)
  3. Oklahoma (29.1)
  4. North Dakota (30.2)
  5. Delaware (30.7)
  6. West Virginia (30.98)
  7. Tennessee (31.0)
  8. Utah (32.3)
  9. Alabama (32.9)
  10. Kentucky (33.5)

Rankings of the five biggest metro areas in the US:

  1. Chicago (45.2 million/mL)
  2. Seattle (44.3)
  3. Los Angeles (40.3)
  4. Dallas (40.3)
  5. New York (39.6)

Why did each state and city rank as it did? While there is no definite answer to this question, sperm health is affected by many factors, including diet, activity level, body composition, sleep quality, stress, alcohol and drug use, and environment.

Why is this important now? The environment is impacting sperm health. Scientists say exposure to endocrine-disrupting chemicals (such as the "forever chemicals" PFAS and phthalates) is the primary reason the average sperm count has declined by 50% over the past 50 years1, and we could be facing a "sperm crisis" by the year 20452. Air quality and rising climate temperatures have also been correlated to poor sperm health: pollution is toxic to sperm, as are extremes in temperature.3 4

Considering these factors, it makes sense that several of the country's hottest states are in the bottom 10 for sperm production, while cooler states rank higher. Additionally, states with lower scores in other health metrics (such as air quality or access to healthcare) also rank lower for sperm health.

"Taken from Legacy's data, our ranking of the best and worst states for sperm health underlines the fact that sperm quality can't be taken for granted ? it really can vary, depending on where you live and how healthy you are," said Khaled Kteily, Legacy's CEO. "The environment will continue to impact sperm, and sperm health naturally declines with age. That's why it's time to save our sperm?every man should get his sperm tested, and consider freezing his youngest, healthiest sperm for the future."

Legacy is exploring the effects of the environment on sperm health throughout April.

For the complete report on the best and worst states for sperm health, visit https://www.givelegacy.com/the-united-states-of-sperm-quality/.

For more information or to schedule an interview with Legacy CEO Khaled Kteily, please contact Rebecca Silver at [email protected].

ABOUT GIVE LEGACY, INC.

As the largest fertility clinic for people with sperm in North America, Legacy offers clients the ability to test their sperm from the comfort of their homes and preserve their fertility for future use. Legacy's fertility solutions are trusted by leading health plans, employee benefits providers, and the US Department of Veterans Affairs.

Founded at Harvard University in 2018, Legacy pioneered direct access to male fertility information, as the only company that allows customers to complete semen analysis, DNA fragmentation analysis, STI testing, and sperm cryopreservation without leaving their homes. Legacy is currently available across the United States. We're the only digital fertility clinic to offer post-thaw analysis to ensure a client's sperm is viable for freezing, and multi-site storage to maximize the security of all samples.

Testing and addressing male fertility first can reduce treatment costs and drive better outcomes. Through the Legacy website, consumers can access a range of educational content, personalized fertility consultations, and other services that promote lifelong sperm health and wellness. To learn more about Legacy, visit us at givelegacy.com.

References

1 https://healthpolicy-watch.news/decline-in-sperm-count-environmental-ties/
2
Swan, Shanna, Count Down: How Our Modern World Is Threatening Sperm Counts, Altering Male and Female Reproductive Development, and Imperiling the Future of the Human Race, 2021
3 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435904/
4
https://www.sciencedirect.com/science/article/pii/S2405844024027968

SOURCE Legacy


These press releases may also interest you

at 01:30
XRP Healthcare proudly announces its sponsorship of the upcoming Ehlers-Danlos Society event in Philadelphia this July 17th ? 21st....

at 01:15
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced positive results from the Phase Ib clinical trial of CT-388, a dual GLP-1/GIP receptor agonist being developed for the treatment of obesity and type 2 diabetes. The...

at 00:00
Author Kory L. Wilson and his family have experienced the benefits of information he shares in Home Remedies: A Guidebook To Breaking Away From Big Pharma ($15.99, paperback, 9781662896668; $6.99, e-book, 9781662896675). For years, I have collected...

15 mai 2024
Full year 2023 revenue of $90.9 million compared to $99.4 million in 2022, and $90.5 million compared to $86.7 million on a normalized basis, excluding one-time COVID mandates.Q4 2023 gross profit margin1 of 39.7% was relatively flat compared to Q3...

15 mai 2024
On 13 May 2024, Fortune China magazine released the 2024 China ESG Impact List, and Fosun International Limited ("Fosun International" or the "Company") (HKEX stock code: 00656) was included in the list, highlighting its outstanding performance and...

15 mai 2024
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that the latest results from five studies have been selected for...



News published on and distributed by: